InvestorsHub Logo
Followers 275
Posts 32725
Boards Moderated 0
Alias Born 11/14/2013

Re: hyperopia post# 599454

Thursday, 06/08/2023 6:56:35 AM

Thursday, June 08, 2023 6:56:35 AM

Post# of 703926
Great post on FDA (very recent) draft guidance concerning MOA. It’s funny, earlier that morning I was somehow compelled to point out folks in the U.K. started, in 2018, to recommend MOA be prepared for all drug approval processes. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172075060&txt2find=Yeah

And also posted EMA requires of Method of Action https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172057034&txt2find=Yeah

I think we can safely say, imo, Dr. Bosch’s presentation addressed those guidances, recommendations and requirements. Even though that particular presentation may not have had regulators present. On the other hand, I do wonder if one or more regulators were present at Industry Expert Theater.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News